1Inhibiting the release of TGF-β from tumor cells, which impairs the action of T cells2Facilitating the maturation of DCs to enhance the APP activity3Increasing the expression of Fas on the surfaces of tumor cells. This evidence concerns the gene APP and neoplasm.